To investigate whether early IFN-γ needed to suppress TFH differentiation in the s.c. LCMV infection also targets CD4+ T cells, we applied Crispr/Cas9 technology to delete IFNGR1 from primary Smarta CD4+ T cells (Fig. 7A). The gene discussed is IFNGR1; the disease is infection.